United States Contraceptive Market Report & Forecast 2021-2027

This report contains market size and forecasts of Contraceptive in United States, including the following market information:
United States Contraceptive Market Revenue, 2016-2021, 2022-2027, ($ millions)
United States top five Contraceptive companies in 2020 (%)
The global Contraceptive market size is expected to growth from US$ XX million in 2020 to US$ XX million by 2027; it is expected to grow at a CAGR of XX% during 2021-2027.
The United States Contraceptive market was valued at US$ XX million in 2020 and is projected to reach US$ XX million by 2027, at a CAGR of XX% during the forecast period.
QYResearch has surveyed the Contraceptive Companies and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
United States Contraceptive Market,

By Type

, 2016-2021, 2022-2027 ($ Millions)
United States Contraceptive Market Segment Percentages,

By Type

, 2020 (%)
Contraceptive Drugs
Contraceptive Devices

United States Contraceptive Market,

By Application

, 2016-2021, 2022-2027 ($ Millions)
United States Contraceptive Market Segment Percentages,

By Application

, 2020 (%)
Hospital
Clinic
Other

Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Contraceptive revenues in United States market, 2016-2021 (Estimated), ($ millions)
Key companies Contraceptive revenues share in United States market, 2020 (%)
Further, the report presents profiles of competitors in the market, key players include:
Bayer
Merck
Church & Dwight
Warner Chilcott Company
Pfizer
Ansell Limited
Mylan
Teva